Apexian, formerly ApeX Therapeutics, is developing a drug therapy for pancreatic cancer. Company officials are working to take it into clinical trials.
Apexian licenses the technology through Indiana University Research and Technology Corporation. You’ll read more about the company and its drug candidate in this Xconomy.com article.
Leave a Reply